12/28/2012 - 12:30pm

Solidifying Perrigo’s leadership position in topical foam-based generic prescription pharmaceuticals, the company announced it has signed a definitive merger agreement and completed the acquisition of Cobrek Pharmaceuticals.

12/28/2012 - 12:14pm

Mylan on Friday announced that its subsidiary, Mylan Pharmaceuticals, has received final approval from the U.S. Food and Drug Administration for its phenytoin chewable tablets USP in the 50 mg strength.

12/28/2012 - 12:08pm

A federal judge in Washington has dismissed a suit against the FDA brought up by Mylan for withholding approval for the company to sell a generic version of Novartis AG’s heart pill, Diovan.

12/28/2012 - 11:49am

Mylan on Friday announced that its partner Famy Care has received final approval from the Food and Drug Administration for its abbreviated new drug application for levonorgestrel and ethinyl estradiol Tablets USP in the 0.15mg/0.03mg strength.

12/28/2012 - 11:47am

Teva Pharmaceuticals USA will delay the sales of generic versions of two Gilead Sciences HIV drugs until June 2013, the company stated.

12/27/2012 - 5:01pm

Rite Aid's fundamentals are improving, and Wall Street has taken notice.

12/27/2012 - 10:11am

The National Institute on Drug Abuse last week released the 2012 Monitoring the Future survey, finding that 5.6% of high school seniors, 3% of eighth graders and 4.7% of tenth graders abused over-the-counter cough and cold medicines containing dextromethorphan, bringing the overall average to under 5%.

12/21/2012 - 12:35pm

Teva Pharmaceutical Industries is buying $1 billion worth of its debt, the Israeli drug maker said.

12/21/2012 - 12:15pm

Watson Pharmaceuticals will present at two conferences sponsored by financial banks, the company said.